Verification of the Ventana Anti-ALK (D5F3) Antibody in the Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer

被引：0
|
作者：
Narine, Nadira
Rana, Durgesh
机构：
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2015年 / 144卷
关键词：
D O I：
10.1093/ajcp/144.suppl2.086
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
086
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [1] Verification and Implementation of the VENTANA Anti-ALK D5F3 Antibody in Detecting ALK Rearrangement in NSCLC
    Nadira, N.
    Al-Najjar, H.
    Higgins, C.
    Wallace, A.
    Harris, J.
    Bailey, S.
    Shelton, D.
    Thiryayi, S.
    Rana, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1950 - S1950
  • [2] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
    Verzura, Maria
    Batagelj, Emilio
    Bagnes, Claudia
    Martin, Claudio
    Enrico, Diego
    Richardet, Eduardo
    De la Iglesia, Paola
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
  • [3] EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
    Martelli, Maria Paola
    Sozzi, Gabriella
    Hernandez, Luis
    Pettirossi, Valentina
    Navarro, Alba
    Conte, Davide
    Gasparini, Patrizia
    Perrone, Federica
    Modena, Piergiorgio
    Pastorino, Ugo
    Carbone, Antonino
    Fabbri, Alessandra
    Sidoni, Angelo
    Nakamura, Shigeo
    Gambacorta, Marcello
    Luis Fernandez, Pedro
    Ramirez, Jose
    Chan, John K. C.
    Grigioni, Walter Franco
    Campo, Elias
    Pileri, Stefano A.
    Falini, Brunangelo
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (02): : 661 - 670
  • [4] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Bilgin, Burak
    Sendur, Mehmet Ali Nahit
    Yucel, Sebnem
    Hizal, Mutlu
    Guner, Gurkan
    Akyurek, Nalan
    Erol, Cihan
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    Kilickap, Sadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
  • [5] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Burak Bilgin
    Mehmet Ali Nahit Şendur
    Şebnem Yücel
    Mutlu Hizal
    Gürkan Güner
    Nalan Akyürek
    Cihan Erol
    Muhammed Bülent Akıncı
    Didem Şener Dede
    Bülent Yalçın
    Sadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643
  • [6] The biology and treatment of EML4-ALK non-small cell lung cancer
    Sasaki, Takaaki
    Rodig, Scott J.
    Chirieac, Lucian R.
    Janne, Pasi A.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (10) : 1773 - 1780
  • [7] EML4-ALK fusion gene in non-small cell lung cancer
    Lei, Yu
    Lei, Yan
    Shi, Xiang
    Wang, Jingjing
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [8] Detection of ALK rearrangement in cytological specimens of non-small cell lung cancer: Accuracy of immunocytochemistry with the D5F3 clone
    Ilie, M.
    Kern, I.
    Hofman, P.
    VIRCHOWS ARCHIV, 2014, 465 : S48 - S49
  • [9] Reliability Assurance of EML4-ALK Rearrangement Detection in Non-Small Cell Lung Cancer: A Methodological and Statistical Issue
    Sabour, Siamak
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : E92 - E93
  • [10] Simultaneous detection of ALK gene and protein in NSCLC biopsies using FISHbreak apart and ALK/EML4 fusion probe and anti-ALK D5F3 rabbit monoclononal antibody
    Plank, L.
    Barthova, M.
    Balharek, T.
    Farkasova, A.
    Hutka, Z.
    Janakova, L.
    Kviatkovska, Z.
    Scheerova, K.
    VIRCHOWS ARCHIV, 2015, 467 : S42 - S42
12345